Cas:874288-35-4 {3-[(2-Fluorophenyl)carbamoyl]phenyl}boronic acid manufacturer & supplier

Chemical Name:{3-[(2-Fluorophenyl)carbamoyl]phenyl}boronic acid

CAS.NO:874288-35-4

Synonyms:{3-[(2-Fluorophenyl)carbamoyl]phenyl}boronic acid;Boronic acid, B-[3-[[(2-fluorophenyl)amino]carbonyl]phenyl]-;[3-[(2-fluorophenyl)carbamoyl]phenyl]boronic acid

Molecular Formula:C₁₃H₁₁BFNO₃

Molecular Weight:259.041

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.3±0.1 g/cm3

Index of Refraction:1.606

PSA:69.56000

Exact Mass:259.081604

LogP:1.96

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like {3-[(2-Fluorophenyl)carbamoyl]phenyl}boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[3-[(2-fluorophenyl)carbamoyl]phenyl]boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Boronic acid, B-[3-[[(2-fluorophenyl)amino]carbonyl]phenyl]- Use and application,Boronic acid, B-[3-[[(2-fluorophenyl)amino]carbonyl]phenyl]- technical grade,usp/ep/jp grade.

Related News: Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets. {3-[(2-Fluorophenyl)carbamoyl]phenyl}boronic acid manufacturer Once they have decided how to make the compound, our staff in the production department manufacture a high quantity of APIs using the large reactors in our plant. {3-[(2-Fluorophenyl)carbamoyl]phenyl}boronic acid supplier Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs. {3-[(2-Fluorophenyl)carbamoyl]phenyl}boronic acid vendor Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells. {3-[(2-Fluorophenyl)carbamoyl]phenyl}boronic acid factory Once they have decided how to make the compound, our staff in the production department manufacture a high quantity of APIs using the large reactors in our plant.